Purpose
to define a biosignature for increased risk of developing TB to: (i) accelerate clinical vaccine trials, (ii) facilitate design of preventive drug therapy and (iii) provide guidelines for improved diagnosis.
Grantee
Division
Global Health
Date
NOVEMBER 2012
Region served
GLOBAL
Committed amount
$1,762,708
Grant topic
Tuberculosis
Duration (months)
50
Grantee location
Planegg, Bayern, Germany
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.